Evidence map›Paper›PMID 31440920›Full record

Observational studyJournal of endocrinological investigation2020

Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study.

V Gasco, L Roncoroni, M Zavattaro, C Bona, A Berton, E Ghigo, M Maccario, S Grottoli

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Journal of endocrinological investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

V GascoDivision of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy. valentina.gasco@unito.it.ORCID http://orcid.org/0000-0002-6491-5731
L RoncoroniDivision of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy.
M ZavattaroDivision of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy.
C BonaDivision of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy.
A BertonDivision of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy.
E GhigoDivision of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy.
M MaccarioDivision of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy.
S GrottoliDivision of Endocrinology, Diabetes and Metabolism, Department of Medical Science, University of Turin, Turin, Italy.
University of Turin · ITDepartment of Medical Sciences · BY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeUncertainties exist about the predictors of the severity of the clinical picture of GH deficiency (GHD) syndrome. Aim of the study was to evaluate, in adult patients with GHD, the predictors of the development of hypercholesterolemia, hypertension, diabetes mellitus, and osteoporosis.

methodsWe retrospectively studied 327 adult patients (age 47.1 ± 17.1 years) with untreated severe GHD (mean follow-up 110.9 ± 56.8 months). GHD was defined by GHRH + arginine test using BMI cut-offs. The possible development of hypercholesterolemia, hypertension, diabetes mellitus, and osteoporosis was investigated by Kaplan-Meier survival analysis. For each clinical outcome, either a univariate or multivariate analysis according to the Cox proportional-hazards model was performed to identify those factors that were associated with the development of the event.

resultsGH secretion parameters were not associated with the outcomes. Hypercholesterolemia was positively and negatively predicted by a BMI ≥ 30 kg/m

conclusionsThe severity of the impairment of GH secretion does not predict the development of the clinical picture of GHD syndrome: untreated adult GHD does not increase the development of metabolic risk factors in hypopituitaric patients.

Indexed as

AdultCohort StudiesDiabetes MellitusDwarfism, PituitaryFemaleFollow-Up StudiesHuman Growth HormoneHumansHypertensionInsulin-Like Growth Factor IMaleMetabolic DiseasesMiddle AgedRetrospective StudiesHuman Growth HormoneIGF1 protein, humanInsulin-Like Growth Factor IDiabetes mellitusGH deficiency syndromeHypercholesterolemiaHypertensionOsteoporosisPredictors

Identifiers

PMID31440920
OpenAlexW2969623793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.